Long-acting technologies
36 articles
Excitement Builds for Long-Acting TB Treatments, but Research Still at Early Stage
Researchers are working on new long-acting formulations that might, for example, reduce an entire course of TB preventive therapy to a single injection. More
Webinar: How People Affected by HCV & TB Feel About Potential Long-Acting Therapies
Webinar, hosted by TAG and Afrocab, to share findings from surveys conducted under the Unitaid-funded LONGEVITY Project. More
Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
TAG releases an advocacy brief discussing findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on potential long-acting therapies for HCV cure. More
Webinar: LONGEVITY Community Engagement: Perspectives of People with HCV and TB Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
TAG and Afrocab hosted a webinar to share findings from surveys conducted under the Unitaid-funded LONGEVITY Project. More
Webinar: LONGEVITY Community Engagement: Perspectives of People with HCV and TB Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
TAG and Afrocab hosted a webinar to share findings from surveys conducted under the Unitaid-funded LONGEVITY Project. More
